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Heterologous expression, purification, reconstitution and kinetic 
analysis of an extended type II polyketide synthase 
Robert JX Zawadal and Chaitan Khosla1y213 
Background: Polyketide synthases (PKSs) are bacterial multienzyme systems 
that synthesize a broad range of natural products. The ‘minimal’ PKS consists of 
a ketosynthase, a chain length factor, an acyl carrier protein and a malonyl 
transferase. Auxiliary components (ketoreductases, aromatases and cyclases) 
are involved in controlling the oxidation level and cyclization of the nascent 
polyketide chain. We describe the heterologous expression and reconstitution 
of several auxiliary PKS components including the actinorhodin ketoreductase 
(act KR), the griseusin aromatase/cyclase (gris AROXYC), and the 
tetracenomycin aromatase/cyclase (tcm AROEYC). 
Results: The polyketide products of reconstituted act and tcm PKSs were 
identical to those identified in previous in viva studies. Although stable protein- 
protein interactions were not detected between minimal and auxiliary PKS 
components, kinetic analysis revealed that the extended PKS comprised of the act 
minimal PKS, the act KR and the gris ARO/CYC had a higher turnover number 
than the act minimal PKS plus the acf KR or the acf minimal PKS alone. Adding 
the km ARO/CYC to the tcm minimal PKS also increased the overall rate. 
Conclusions: Until recently the principal strategy for functional analysis of PKS 
subunits was through heterologous expression of recombinant PKSs in 
Streptomyces. Our results corroborate the implicit assumption that the product 
isolated from whole-cell systems is the dominant product of the PKS. They also 
suggest that an intermediate is channeled between the various subunits, and 
pave the way for more detailed structural and mechanistic analysis of these 
multienzyme systems. 
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Introduction 
Aromatic polyketides are a large family of structurally 
diverse natural products that have many important antibi- 
otic and pharmacological properties. This class of natural 
products is synthesized by bacteria that have type II 
polyketide synthases (PKSs) that are structurally and 
mechanistically related to bacteria1 type II fatty acid syn- 
thases (FASs) [l-3]. Both classes of synthases are multi- 
functional enzymes that catalyze repeated decarboxylative 
condensations between acylthioesters (usually a growing 
polyketide chain and a malonyl extender unit). However, 
type II PKSs and FASs differ in the oxidation level of 
their products, the ability of PKSs to regiospecifically 
reduce certain P-keto groups, and the ability of PKSs to 
catalyze regiospecific intramolecular cyclizations on the 
polyketide backbone. 
The structural diversity and medicinal relevance of their 
products have motivated intensive manipulation and analy- 
sis of the molecular recognition features of PKSs. Much of 
this manipulation was carried out using a host-vector 
system in Streptomyces coelicolor that enabled the efficient 
construction and expression of recombinant PKS gene sets 
[4]. These recombinants provided a means to decipher the 
role(s) of individual subunits of the PKS in the overall cata- 
lytic cycle, as well as to dissect their substrate specificity 
[4-161. In turn, these insights were used to develop a set of 
‘design rules’ to engineer recombinant PKS gene clusters 
that generated novel polyketides in a predictable manner. 
This capability has opened the possibility of generating 
polyketide libraries through combinatorial biosynthesis 
[16,17]. More recently, the properties of a class of subunits, 
the aromatase/cyclases (ARO/CYCs) have been further dis- 
sected using gene fusions. Their didomain architecture 
was established by expressing the domains as separate 
polypeptides and chain-length specificity was mapped to 
the amino-terminal domain of these subunits [18]. 
Although the above genetic studies have led to many new 
insights into aromatic PKS mechanism and specificity, 
their utility is largely limited to qualitative analysis of these 
multifunctional systems. To overcome this shortcoming, in 
vitro systems have also been developed. Cell-free activity 
of both minima1 [19,20] and extended PKSs [ZO] have been 
demonstrated. More recently, the components of the 
minimal PKS have been purified and reconstituted for 
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Proposed biosynthetic pathway catalyzed by 
the actinorhodin (act) PKS. After biosynthesis 
of the full polyketide chain by the minimal 
PKS, which includes a ketosynthase (KS), a 
chain length factor (CLF), an acyl carrier 
protein (ACP) and malonyl CoA:ACP 
transacylase (MAT), the nascent octaketide 
chain is altered by various downstream 
subunits. The ketoreductase (KR) reduces the 
C9 carbonyl. The AROlCYC aromatizes this 
reduced first ring. In systems lacking a full 
complement of these subunits, shunt 
products are produced. (Biosynthetic 
intermediates are purely hypothetical.) 
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both the actinorhodin (act) [Zl]) and tetracenomycin @cm) 
[ZZ] systems. These minimal PKSs include a ketosyn- 
thase-chain length factor (KS-CLF) heterodimer, an acyl 
carrier protein (ACP), and a malonyl-CoA:ACP malonyl 
transferase (MAT). (There is some debate about the 
absolute necessity of the MAT in a reconstituted system; 
under physiologically relevant concentrations of the ACP, 
however, the presence of the MAT has a significant impact 
on the kinetics of this multicomponent system [23,24].) 
Here we describe the purification, reconstitution and in 
vitro analysis of extended PKS systems composed of the 
act minimal PKS, the act ketoreductase (KR) and the 
didomain griseusin (gris) aromatase/cyclase (ARO/CYC). 
We used the gn.r ARO/CYC here because the act 
ARO/CYC could not be expressed at sufficiently high 
levels. In addition, the monodomain tetracenomycin @cm) 
ARO/CYC, tcmN, was reconstituted with the tcm minimal 
PKS. Unlike earlier work in which the full-length tcmN 
gene was expressed [22,25], here we only express the 
ARO/CYC domain of tcmN, which we refer to as the tnn 
ARO/CYC in this manuscript. 
The act KR is involved in reducing the C9 carbonyl group 
of the nascent polyketide chain [8,26]. The gtis ARO/CYC 
is a didomain protein [l&27] that is required for the aroma- 
tization of the first carbocycle in polyketide chains that 
have been reduced at the C9 position by the KR (Figure 1) 
[13]. The tcm ARO/CYC influences the regiospecificity of 
cyclization of unreduced (but not reduced) polyketide 
backbones. In its absence, the unreduced nascent polyke- 
tide can undergo either a C7/C12 or C9/C14 cyclization; in 
contrast, in its presence only the C9/C14 cyclization is 
observed [14,15,25] (Figure 2). The tcm ARO/CYC may also 
be involved in the aromatization of the second ring [14]. 
Results 
Heterologous expression of the act KR, gris ARWCYC and 
tcm ARO/CYC 
The act KR, gtis ARO/CYC and tcm ARO/CYC genes were 
cloned into an Eden&a coli expression vector (pETZlc) 
generating plasmids pRZ153, pRZ112 and pRZ106, 
respectively, as described above. Following disruption of 
the E. coli cells and centrifugation, the supernatants were 
analyzed using sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). The act KR and tcm 
ARO/CYC were clearly identifiable in crude extracts at 
their corresponding molecular masses (27 and 20 kDa 
respectively); the gris ARO/CYC (37 kDa), in contrast, was 
not obviously detectable (see Figure 3, lanes 2, 8 and 14). 
In order to verify that these proteins were synthesized in 
an active form, they were assayed with the minimal PKS. 
The results of these assays are described below. 
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Figure 2 
Proposed biosynthetic pathway catalyzed by 
the tetracenomycin (km) PKS. After 
biosynthesis of the full polyketide chain by 
the minimal PKS, which includes a KS, a CLF, 
an ACP and a MAT, the nascent decaketide 
chain cyclizes in a number of ways. In the 
absence of the tcm AROICYC, the nascent 
polyketide chain will condense between the 
C7 carbonyl and Cl 2 methylene or between 
the C9 carbonyl and Cl 4 methylene leading 
to the formation of SEK15 and SEKl5b, 
respectively. The tcm AROlCYC catalyzes 
an aldol condensation between the C9 
carbonyl and Cl 4 methylene leading to the 
production of RM80. The tcm AROlCYC may 
also be involved in the aromatization of the 
second ring. (Biosynthetic intermediates are 
purely hypothetical.) 
-- 
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, Chemistry 8 &log) 
Purification of the act KR, gris ARO/CYC and tcm ARO/CYC 
Crude extracts of E. coli BLZl(DE3)/pRZ106, pRZ112 or 
pRZ153 were fractionated, and fractions were assayed for 
their ability to catalyze biosynthesis of the expected 
polyketides. The act KR was applied to butyl sepharose, 
which gave a 70% enriched preparation of KR. Further 
purification of this preparation using hydroxyapatite and 
anion-exchange chromatography resulted in a nearly 
homogeneous (> 95% pure) sample of act KR (Figure 3a). 
Approximately 10 mg of act KR was obtained from each 
liter of E. coli BLZl(DE3)/pRZ153 culture. 
The grir ARO/CYC was applied to a high-performance 
phenyl sepharose column, which resulted in a 10% enriched 
Figure 3 
preparation of ARO/CYC. This material was then processed 
using anion-exchange chromatography and gel-filtration chro- 
matography. The final preparation was nearly homogeneous 
in gris ARO/CYC (~95% pure) (Figure 3b). Each liter of 
E. col’z’BL21(DE3)/pRZ112 yielded -1 mg ofgrir ARO/CYC. 
The tcm ARO/CYC was purified by anion-exchange chro- 
matography followed by cation-exchange chromatography. 
The anion-exchange column yielded an 80% enriched 
preparation of ARO/CYC, whereas the cation-exchange 
column yielded a nearly homogeneous sample (> 95% 
pure) of the tcm ARO/CYC domain (Figure 3~). Each 
processed liter of E. coli BLZl(DE3)/pRZ106 yielded 
-20 mg of tcm ARO/CYC domain. 
Purification gels for the acf ketoreductase 
(KR), gris AROICYC and tcm AROICYC 
domain. (a) Purification gel of the act KR. 
Lanes 1 and 7 are molecular mass markers; 
lane 2, crude extract of BL21 (DEB)/pRZ153; 
lane 3, extract of BL21 (DES)/pRZ153 
following PEI and (NH,),SO, precipitation; 
lane 4, act KR after Butyl sepharose 
chromatography; lane 5, act KR following 
hydroxyapatite chromatography; lane 6, act 
KR after Resource C. (b) Purification gel of 
gr;s AROICYC. Lane 8, BL21 (DES)IpRZll2 
after PEI and (NH,),SO, precipitation; 
lane 9, gris AROlCYC following phenyl 
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sepharose HP chromatography; lane 10, gns 
ARO/CYC after Resource Q; lane 11, gris 
AROlCYC following size exclusion domain. Lanes 13 and 17 are molecular lane 15, km AROlCYC domain following 
chromatography; lane 12, molecular weight mass markers; lane 14, BL21 (DE3)lpRZ106 HiTrap Q; lane 16, km AROlCYC domain 
marker. (c) Purification gel for tcm ARO/CYC after PEI and (NH&SO, precipitation; after HiTrap SP. 
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Figure 4 
HPLC analysis with UV absorbance for in vitro assays of PKS systems. 
(a) Extract from assay of the act minimal PKS and SEK4,b standards. 
(b) Extract from assay of the act minimal PKS plus act KR and mutactin 
standard. (c) Extract from assay of the act minimal PKS plus act KR 
and gris AROlCYC along with SEK34 standard. (d) Extract from assay 
of tcm minimal PKS plus tcm AROlCYC domain and RM80 standard. 
Verification of the act KR, gris ARWCYC and tcm 
ARO/CYC activities 
The activity of the act KR was assessed by assaying this 
protein in the presence of the act KS-CLF, f&n ACP and 
MAT. The fren ACP was used because it was already 
cloned into an E. co& expression system that could 
phosphopantetheinylate the ACP. The gris ARO/CYC was 
assayed in combination with the act KR, act KS-CLF,fren 
ACP and MAT. The tcm ARO/CYC domain could not be 
assayed in a&o using the act minimal PKS because the 
reported biosynthetic product of the act minimal PKS plus 
tcmN undergoes oxidation by an unknown oxidase. The 
tcm ARO/CYC domain was therefore assayed using puri- 
fied tnn minimal PKS, because the predicted product was 
expected to be generated in vitro. 
Three reactions were set up for each of these systems. One 
reaction included radiolabeled malonyl CoA that was 
extracted and analyzed on a silica gel thin layer chromato- 
graphy (TLC) plate along with purified standards. The 
other reactions included unlabeled malonyl CoA. One of 
these was analyzed using high-performance liquid chro- 
matography (HPLC)-UV detection; the other was sub- 
jected to atmospheric pressure chemical ionization (AP- 
CI) mass spectroscopic analysis. Figure 4 shows the results 
of HPLC analysis, along with reference products for the 
three systems. The results obtained by mass spectroscopy 
agreed with the expected masses for the products. 
Oligomerization studies 
The act KR, gn> ARO/CYC and tcm ARO/CYC domain 
were analyzed separately over a Superdex 200 column to 
estimate their apparent molecular weights (MWs) 
(Figure 5). The act KR eluted at 15.4 ml, which corresponds 
to an apparent MW of 46 kDa, the gni ARO/CYC eluted at 
15.6 ml, which corresponds to an apparent MW of 37 kDa 
and the tcm ARO/CYC eluted at 16.9 ml, which correspond 
to an apparent molecular weight of 20.8 kDa. The apparent 
molecular weights of the gti5 ARO/CYC and tcm ARO/CYC 
domain were consistent with their monomeric molecular 
weights. (Note that Shen and Hutchinson [ZS] demon- 
strated by gel-filtration chromatography that the full length 
tcmN gene product exists as a dimer.) The act KR had an 
apparent MW suggestive of a dimer, however. Cross-linking 
experiments were therefore undertaken to investigate 
whether a dimer could be directly identified. Indeed, 
SDS-PAGE analysis revealed a cross-linked species with 
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an observed molecular mass consistent with that of a KR 
dimer when glutaric dialdehyde was used as the cross- 
linking agent (data not shown). Moreover, when the act KR 
was purified on Resource Q, it eluted as two distinct peaks, 
both of which displayed KR activity. This suggests that the 
act KR exists in equilibrium between two distinct states, 
possibly a monomer and dimer. 
In addition to determining apparent MWs, experiments 
were performed on the gel-filtration column to determine 
if complexes between the various PKS subunits could be 
observed directly. The act KR was combined with the g?G 
ARO/CYC with and without thefren ACP. In addition, the 
act KS/CLF and thefren ACP were applied in conjunction 
with either the act KR, tcm ARO/CYC domain, or act KR 
plus grir ARO/CYC. None of these combinations led to 
new higher MW peaks, suggesting the absence of any 
stable complexes in these mixed incubations. 
Kinetic studies of PKSs containing the act KR and gris 
ARWCYC 
The rates of polyketide production for the act minimal PKS 
were found to be linear from O-30 min (S-15 turnovers); all 
rates were therefore computed from samples harvested in 
this time range. The k,,, for mutactin formation was found 
to be 0.11 jI 0.02 min-l, whereas the k,, for SEK34 forma- 
tion was found to be 0.44 If: 0.04 mine’. These numbers 
compare favorably with the k,,, for SEK4 and SEK4b pro- 
duction by the minimal PKS (0.33 f 0.06 min-l). In order 
to determine whether the rate enhancement observed 
with the addition of ARO/CYC was due solely to the pres- 
ence of additional nonspecific protein, 10 PM BSA was 
added to a reaction mixture of the act minimal PKS. Addi- 
tion of bovine serum albumin (BSA) had no effect on the 
overall rate of the minimal PKS. In order to determine 
whether the decrease in overall rate observed when the act 
KR is included with the act minimal PKS was because of 
product inhibition, we carried out side-by-side assays of 
the act minimal PKS plus act KR in the presence and 
absence of 60 PM mutactin (the product of the act 
minimal PKS plus act KR). Again, addition of mutactin 
had no effect on the overall rate of polyketide synthesis. 
In order to gain insight into the stoichiometry of the 
various components in these extended PKSs, the act KR 
and gn> ARO/CYC were titrated into an assay mixture 
containing 0.5 PM act KS-CLF, 0.5 FM MAT and 20 PM 
frpn ACP. This corresponds to the highest experimentally 
achievable concentration of the KS-CLF; moreover, 
under these conditions the activity of the minimal PKS is 
saturated with respect to MAT and ACP [24]. The results 
of these titrations are shown in Figures 6 and 7. From 
these results a clear difference can be seen between the 
stoichiometry of the KR and the ARO/CYC required for 
optimal PKS activity. The concentration of the act KR at 
which mutactin was synthesized at 50% of the maximum 
Figure 5 
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Estimation of the molecular weights of the act KR, gris AROlCYC and 
tcm AROlCYC domains using gel filtration chromatography. 
K,, = (V, - V,)l( V, - V,). V, and V, were determined using blue dextran 
and tyrosine, respectively. 
rate was 3.12 + 0.62 PM. In contrast, the concentration of 
the gn> ARO/CYC at which SEK34 was synthesized at 
50% of the maximum rate was only 50 +_ 10 nM. 
Kinetic studies of the tcm minimal PKS and tcm minimal 
PKS plus tcm ARWCYC 
The rate of polyketide production for the tcm minimal PKS 
was found to be linear from O-30 min (lo-50 turnovers); 
all rates were therefore computed from samples collected 
in this time range. Interestingly, the k,, for the tcm 
minimal PKS (1.40 f 0.25 min-I) was found to be fourfold 
greater than that of the act minimal PKS (0.33 + 
0.06 mine’) despite the fact that the tcm PKS must 
perform two additional condensations. 
In contrast to findings in viva in which the primary prod- 
ucts of the minimal tcm PKS were SEK15 and SEKlSb, 
[8,12,14] in vitro assays of the tcm minimal PKS resulted in 
production of SEKlS and SEKlSb (-67% total polyketide) 
as well as significant amounts of RMSO (-33% total polyke- 
tide). The kcat for SEK15 and SEKlSb formation by the tcm 
minimal PKS was found to be 0.95 f 0.11 min-l, whereas 
the k,,, for RM80 formation by the minimal PKS was found 
to be 0.46 f 0.15 min-l. Addition of tcm ARO/CYC (5 PM) 
resulted in an increase in the overall rate of polyketide syn- 
thesis to 2.55 + 0.31 min-I, with the rate of RM80 synthesis 
increasing to 1.79 + 0.17 min-l and the rate of SEK15 and 
SEKlSb synthesis decreasing to 0.75 + 0.15 min-‘. 
The tcm ARO/CYC was titrated into an assay mixture con- 
taining the tcm minimal PKS at concentrations sufficient 
for its maximal rate (0.25 PM tcm KS-CLF, 0.1 PM MAT, 
and 15 PM fren ACP). The. results of this titration are 
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Figure 6 Figure 6 
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Titration of the act KR. The act KR was titrated into 0.5 PM act KSlCLF 
heterodimer and 20 PM ffeen ACP. The rates were determined from 
extractions harvested at 10, 20 and 30 min and divided by the 
concentration of the KS/CLF heterodimer. 
shown in Figure 8. The concentration of the tcm ARO/ 
CYC at which RM80 was synthesized at 50% of the 
maximum rate was 320 + 80 nM. 
Discussion 
Until recently the principal strategy for dissecting the 
function and specificity of PKS subunits was through het- 
erologous expression and product analysis of recombinant 
PKS gene sets in Stn?ptomyces. An implicit assumption in 
such studies was that the product isolated from whole-cell 
systems was indeed the dominant product of the recombi- 
nant PKS in viva. The results reported here and elsewhere 
corroborate this assumption. For example, the primary 
Figure 7 
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Titration of the gris ARO/CYC. The gris AROICYC was titrated into 
0.5 FM act KSlCLF heterodimer, 20 PM fren ACP and 40 pM act KR. 
The rates were computed from extractions harvested at 10, 20 and 
30 min and divided by the concentration of the KS/CLF heterodimer. 
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Titration of the tcm AROICYC. The fcm AROlCYC was titrated into 
0.25 KM tcm KSICLF, 20 PM fren ACP and 0.1 pM MAT. The rates 
were computed from extractions collected at 10, 20 and 30 min and 
divided by the concentration of the KWCLF heterodimer. 
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products of the act minimal PKS, the act minimal PKS + act 
KR, and the act minimal PKS + act KR +gti.r ARO/CYC 
in viva were reported to be SEK4 and SEK4b [ll], 
mutactin [8,28] and SEK34 [13]. As described above and 
elsewhere [21,23], these are the very same products 
observed in reconstituted cell-free systems. Similarly, the 
primary product of the tcm minimal PKS + tcm ARO/CYC, 
RM80 [14], has also now been confirmed in vitro. Biosyn- 
thetic inferences drawn from structural and isotope label- 
ing studies of recombinant polyketides observed in viva 
can therefore be accepted as a reasonable starting point for 
more detailed mechanistic studies in the future. 
In this study we succeeded in expressing a variety of aux- 
iliary PKS subunits in 8. co/i, and reconstituting them with 
minimal PKSs. The availability of purified protein also 
yielded insights into the assembly of aromatic PKSs into 
higher order complexes. Specifically, size exclusion chro- 
matography revealed that auxiliary PKS components do 
not form stable complexes with minimal PKS subunits. It 
must be kept in mind, however, that these experiments 
were carried out in the absence of substrates. It might be 
that the components only associate in the presence of a 
growing nascent polyketide. Indeed, our kinetic measure- 
ments suggest that interactions at least between the KR 
and/or minimal PKS and the ARO/CYC subunits occur. 
The kc,,, for formation of the fully aromatized product 
formed upon the addition of both the KR and the g& 
ARO/CYC was fourfold higher than the R,,, for formation 
of mutactin (the product of the minimal PKS plus act KR) 
and 33% higher than the R,,, for formation of SEK4 and 
SEK4b (the products of the minimal PKS alone). Because 
the ARO/CYC acts downstream of the KR and the 
minimal PKS in the biosynthetic pathway, the observed 
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rate enhancement probably reflects the channeling of the 
reduced intermediate between the KR and ARO/CYC. 
In addition to the extended act PKS system for which the 
minimal PKS has already been characterized [24], kinetic 
analysis was also performed on the tcm PKS. Initial charac- 
terization of tcm minimal PKS systems revealed that its kcO,,t 
(1.4 f 0.25 min-l) was significantly higher than the k,,, for 
the act minimal PKS systems (0.33 + 0.06 min-I). Addition 
of a downstream subunit, specifically the tcm ARO/CYC, 
also enhanced the rate of polyketide synthesis 1.8-fold 
over the rate for the minimal tcm PKS alone (2.55 min-1 
versus 1.4 min-I). These results are in agreement with the 
findings of Shen and Hutchinson [ZS], in which they 
reported an increase in total polyketide product when the 
tcm ARO/CYC was included with the tcm minimal PKS. 
These results, therefore, represent another example of a 
downstream component enhancing the overall biosyn- 
thetic rate, and further supports the existence of channel- 
ing of intermediates between components of extended 
type II PKSs. 
Titration experiments revealed that the gris ARO/CYC 
saturates the system at significantly lower concentrations 
than the act KR. It is unclear whether this reflects differ- 
ences in protein-protein interaction affinities, or whether 
it is a measure of variable enzyme-substrate affinities. It 
is likely that both properties are captured in these mea- 
surements, because the substrate for the auxiliary sub- 
units is probably bound to the minimal PKS [25]. The 
remarkable differences in saturating concentration levels 
are reminiscent of the large differences between the cor- 
responding parameters for the ACP and the MAT in the 
minimal PKS complex [24]. 
Significance 
Until recently the function and specificity of polyketide 
synthase (PKS) subunits could only be probed through 
heterologous expression and product analysis of recombi- 
nant PKS gene sets in Streptomyces. The work presented 
here demonstrates the feasibility of expressing and recon- 
stituting the activity of an extended aromatic PKS system 
in vitro. This capability has enabled us to analyze steady- 
state kinetic properties, the results of which in turn sug- 
gests that substrates are channeled between the subunits 
of type II PKSs. Further investigations should continue 
to uncover exciting new insights into the mechanism and 
structure of the type II PKSs. Moreover, such reconsti- 
tuted systems may also expand our ability to synthesize 
novel polyketides of practical utility in vitro. 
Materials and methods 
Reagents and chemicals 
[14C]-Malonyl CoA was obtained from Moravek Biochemicals. Malonyl 
CoA was obtained from Sigma Chemical Company. The cross-linking 
reagent glutaric dialdehyde was obtained from Aldrich. Hydroxyapatite 
CHTB-I was procured from Bio-Rad, Butyl Sepharose, Phenyl Sepharose 
6 FF, Phenyl Sepharose HP, HiTrap Cl, HiTrap SP, Resource Q and 
Superdex 200 were obtained from Pharmacia Biotech. 
Strains and culture conditions 
S. coelicolor CH999IpSEK38 [21 I and CH999IpSEK23 [12] were used 
to obtain act KS and CLF and tcm minimal PKS respectively. Mycelia 
from 2 I stationary phase cultures were harvested yielding a 15 g mycelial 
pellet. E. co/i strain BL21 (DE3) was used for expression of the fren ACP, 
act KR, gris AROlCYC and tcm AROlCYC genes. f. co/i was grown in 
1 I of LB (200 pglml carbenicillin). Protein production was induced with 
1 mM IPTG at OD,,, -0.6, following which the cells were then grown for 
-8 h before being centrifuged and resuspended in disruption buffer. 
Gene expression in E. coli 
The first eight codons of the act KR, gr;s AROlCYC and tcm ARO/ 
CYC were optimized for expression in f. co/i using the polymerase 
chain reaction (PCR) and then cloned into the NdellEcoRI sites of 
pET21 c (pRZ153, pRZl12 and pF!ZlO6 respectively). The sequence 
for the act KR (pW153) primers were as follows (restriction enzyme 
sites are italicized and modified bases are shown in bold): 5’-CATATG- 
GCGACCCAGGACTCCGAAGTCGCACTG-3’ and 3’-CTTAAGAGT- 
CATCAAGGGGTCGGGCGGCGT-5’. The primers for the gris ARO/ 
CYC (pRZ112) were as follows: 5’-CATATGTCTCAGCCGGGCCTG- 
CGCGAGGTGGAGCAC-3’ and 3’-CTTAAGAGTCGGGGCGGCC- 
GGGCGCCGT-5’. The primers for the tcm AROlCYC (pRZ106) 
were:’ 5’-CATATGGCAAGCGCGCACGGACAA-3’ and 3’-C77AAG- 
AGTGlTGTCAACGACCCGCA-5’. 
Purification of the PKS proteins 
The act KS-CLF [21] and tcm KS-CLF [22] complexes were purified 
as previously described. The fren ACP, which was coexpressed with 
Sfp, a phosphopantetheinyl transferase (PPTase) from Bacillus subtilis 
[29] for in viva phosphopantetheinylation, was prepared by freeze/thaw 
lysis [30] and Resource Q chromatography as previously reported 
[31]. Cells expressing act KR, gris AROZYC or tcm AROlCYC genes 
were disrupted using a French press at 1300 psi. The crude extracts 
were then precipitated with 70% saturated (NH,),SO,. 
The act KR extract was desalted into 10 mM NaH,PO,, pH 7/NaOH, 
2 mM DTT, 2 mM EDTA, 1 M (NH&SO, (buffer A) and bound to a Butyl 
Sepharose FF column (HR 10130, Pharmacia Biotech). The column was 
washed with 20 ml buffer A followed by a 80 ml gradient at 1 mllmin to 
buffer A lacking (NH,),SO, that went lOO-25% buffer A over 40 ml 
then 25-O% over 40 ml. Peak fractions (act KR 70% of protein) eluting 
at 50-O mM (NH,),SO, were pooled and applied to a hydroxyapatite 
column. The flow through, which contains KR (-90% of protein), was 
desalted into 20 mM Tris, pH E/HCI, 2 mM dithiothreitol (DTlJ, 2 mM 
EDTA, 200/o (v/v) glycerol (buffer B) and applied to an anion exchange 
column (Resource Q; 6 ml column). A gradient from O-O.25 M NaCl in 
buffer B was run at 1 mllmin for 5 min, followed by a gradient from 0.25 
to 0.4 M NaCl at 1 mllmin for 20 min. The KR elutes in a form that is 
greater than 95% pure between 0.30 M and 0.38 M NaCI. 
The gris AROlCYC was desalted into 50 mM NaH,PO,, pH 7/NaOH, 
2 mM DTT, 2 mM EDTA, 0.75 M (NH,),SO, (buffer C) and applied to a 
Phenyl Sepharose HP column (HR 1 O/30, Pharmacia Biotech). A linear 
gradient at 1 mllmin to buffer C lacking (NH,),SO, and containing 
20% (v/v) glycerol was run over 90 min. Fractions containing the gris 
AROlCYC (5% of total protein) which eluted at the end of the gradient 
were desalted into buffer B and applied to a 8 ml Resource Cl column. 
A gradient was developed at 1 mllmin to 0.15 M NaCl in buffer B over 
5 min followed by a gradient to 0.25 M NaCl over 30 min. The gris 
AROlCYC (85% of protein) eluted as a peak around 0.17 M NaCI. The 
purest fractions were pooled and concentrated on Centriprep 10 mem- 
branes (Amicon) to a protein concentration of 3-4 mglml (200 pl total 
volume). The gris ARO/CYC was then chromatographed on a 
Superdex 200 size exclusion column in 100 mM NaH,PO,, pH 7.3/ 
NaOH, 2 mM DTT, 2 mM EDTA (buffer D) where it eluted as a 37 kDa 
protein that was greater than 95% pure. 
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The tcm ARO/CYC was desalted into buffer B and loaded onto an 
anion exchange column (HiTrap C; 2 x 5 ml columns). A gradient at 
1 ml/min was run from O-0.1 5 M NaCl in buffer B over 5 min followed 
by a 30 min gradient at 1 ml/min from 0.15-0.30 m NaCI. Fractions at 
0.18 M NaCI, which contained tcm ARO/CYC (75% of the total 
protein), were pooled and desalted into 50 mM malonic acid, 
pH 5,5/NaOH, 2 mM DlT, 2 mM EDTA, 20% (v/v) glycerol (buffer E) 
and applied to a cationic exchange column (HiTrap SP; 2 x 5 ml 
columns). A linear gradient to 0.20 M NaCl in buffer E was run at 
1 mllmin over 30 min. The tcm ARO/CYC eluted as a fraction that was 
greater than 95% pure at 0.10 M NaCI. 
Assay of PKS activity 
The activity of the act minimal PKS was determined as described previ- 
ously [20,21]. Activities of the act KR and gris AROZYC were deter- 
mined using a similar method with purified act minimal PKS. Unless 
specified otherwise, reaction mixtures (I 00-200 ul) contained 0.5 pM 
KS/CLF, 20 pM holo-ACP, 0.1 uM MAT, 20 pM act KR, 5 uM gris 
AROlCYC (not included when solely assaying KR), 1 mM [14C1malonyl 
CoA (0.35 Ci/mol), 2 mM NADPH, 100 mM NaHsPO,, pH 7.3, 2 mM 
DlT, 2 mM EDTA, 25% glycerol (v/v). Reactions were incubated at 
room temperature for 90 min prior to quenching with 0.1 g of NaH,PO, 
and extracting with 2 x 0.5 ml of ethyl acetate. Ethyl acetate extracts 
were dried in vacua, resuspended in 1 O-l 5 ul ethyl acetate:methanol 
50:50 and run on TLC on silica gel (Baker Si25OF, methanol:acetic 
acid:ethyl acetate 9:1:90) and visualized using electronic autoradiogra- 
phy (Instant Imager, Packard). The activity of the tcm ARO/CYC was 
determined in conjunction with purified tcm minimal PKS. Reaction mix- 
tures (100 ul) consisted of 0.2 pM tcm KSICLF, 20 t.tM holo-ACP, 
0.1 pM MAT, 15 pM fcm AROICYC, 1 mM [14CImalonyl CoA 
(0.35 Ci/mol), 100 mM NaH,PO,, pH 7.3, 2 mM DTT, 2 mM EDTA and 
25% glycerol (v/v). The products of assays of the act KR, gris 
ARO/CYC and fcm AROlCYC were verified by HPLC and AP-Cl mass 
spectrometry of extracts obtained from 500 ul reactions. The extracts 
were compared to standards of mutactin for the act KR, SEK34 for the 
gris AROlCYC and RMBO for the fcm AROICYC. (Note the product 
for the fcm minimal PKS plus fcm AROICYC reported here, RMBO, is 
consistent with the major product found in previous in vivo investiga- 
tions on this system done in this laboratory [I 41. However, in viva and 
in vitro analysis of the tcm minimal PKS plus fcm AROlCYC by 
Hutchinson and coworkers [6,25,32] resulted in a related but different 
product, TCMFP. (The reasons for this discrepancy remain unknown.) 
Kinetic assays for act minimal PKS, act minimal PKS plus act 
KR, and act minimal PKS plus act KR plus gris AROICYC 
Assays for SEK4 and SEK4b, mutactin, and SEK34 (the products of 
the three multienzyme systems, respectively) production were per- 
formed in 400-500 pl reactions with 100 pl time points taken in the 
range of 5-15 enzymatic turnovers. Each time point was extracted 
3x400 ul ethyl acetate. The extracts were dried in vacua, resus- 
pended with 1 O-l 5 ul ethyl acetate:methanol 50:50, and loaded onto 
a TLC plate. The amount of product was determined using standards 
of known specific activity. The concentrations of the proteins were 
determined using the Lowry method and via densitometric scanning. 
Apparent k,, values were calculated under the assumption that the KS 
and CLF formed a heterodimer. 
Kinetic assays for tcm minimal PKS and tcm minimal PKS 
plus tcm ARO/C YC 
Assays for SEKI 5 and SEKl5b [8,121 and RM80 [I 41 (the products of 
the two multienzyme systems, respectively) production were performed 
in 400-500 ul reactions. Reactions for the fcm PKS plus fcm 
AROlCYC consisted of 0.2 uM KS-CLF, 15 t.tM fren ACP, 0.1 uM 
MAT and varying amounts of fcm AROICYC. It was determined that the 
rates of polyketide formation for the fcm PKS were linear in the range of 
1 O-50 enzymatic turnovers: therefore, 100 pl aliquots were extracted in 
this range. Each aliquot was extracted with 3 x 400 ul ethyl acetate. 
The extracts were dried in vacua, resuspended with 1 O-15 pl ethyl 
acetate:methanol 50:50, and loaded onto a TLC plate. The TLC plate 
was developed using a running buffer of ethyl acetate:methanol:acetic 
acid 92:7:1. The amount of product was determined using standards of 
known specific activity. The concentrations of the proteins were deter- 
mined using the Lowry method and via densitometric scanning. Appar- 
ent koat values were calculated under the assumption that the KS and 
CLF formed a heterodimer with one active site. 
Gel-filtration chromatography 
Molecular masses were estimated by applying the act KR (66 PM), gris 
AROlCYC (22.6uM) and fcm AROlCYC (39yM) onto Superdex 
200 pg (AK 26/60, Pharmacia) with 100 mM NaH,PO,, pH 7.3, 2 mM 
DTT, 2 mM EDTA 20% glycerol (v/v) at 0.25 ml/min. These proteins 
were also loaded onto the column in combination with the act KS/CLF 
(3 uM) and ACP (350 PM) to investigate the possibility of complex for- 
mation Elution volumes were determined by absorbance at 280 nm 
and verified using SDS-PAGE. 
Chemical cross-linking 
Purified act KR (46 pM) was equilibrated into buffer B without addition 
of DTT. The cross-linking agent used was glutaric dialdehyde at 1.9 M 
in the enzyme solutions (I 2 ul). The reactions were incubated at 4’C 
and quenched with sodium borohydrate at 2, 3 and 5 min. The protein 
samples were denatured and electrophoretically separated using 12% 
SDS-PAGE. The molecular masses of the cross-linked species were 
estimated with a protein marker ladder (New England Biolabs). 
identification of mutactin, SEK34 and RM80 by HPLC 
The polyketide products mutactin, SEK34 and RM80, generated in 
vifro and extracted with ethyl acetate, were chromatographed on a 
C-l 8 reverse-phase HPLC column. A gradient from O-20% acetonitrile 
in water over 5 min followed by 20-400/o over 45 min at 1 ml/min was 
used for mutactin and SEK34. RM80 was subjected to a gradient from 
0-1000/o acetonitrile in water over 30 min at 1 mllmin. Authentic 
samples were used as references. UV peaks at 280 nm were moni- 
tored using an on-line multi-wavelength detector. The peaks corre- 
sponding to mutactin, SEK34 and RM80 appeared at 29.4%, 28.6% 
and 67% acetonitrile, respectively. AP-Cl mass spectrometry was also 
performed to confirm the molecular weights of the products. 
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